Vycor Medical, Inc. (OTCMKTS:VYCO – Get Free Report) was the recipient of a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 12,092 shares, a decrease of 36.7% from the August 31st total of 19,092 shares. Based on an average trading volume of 26,400 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.0% of the company’s stock are sold short.
Vycor Medical Price Performance
VYCO opened at $0.07 on Friday. The company has a 50-day moving average of $0.07 and a 200-day moving average of $0.07. Vycor Medical has a 1-year low of $0.03 and a 1-year high of $0.20.
Vycor Medical Company Profile
Vycor Medical, Inc develops and commercializes medical devices designed to support minimally invasive neurosurgical procedures. The company’s products are intended to provide surgeons with access to and visualization of the brain while helping protect surrounding tissue.
Its principal product line includes the ViewSite Brain Access System, a tubular retractor and access device designed to create a controlled pathway to surgical targets. The system is used in procedures such as tumor removal, hematoma evacuation and other interventions requiring access to deep areas of the brain.
Featured Stories
- Five stocks we like better than Vycor Medical
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Vycor Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vycor Medical and related companies with MarketBeat.com's FREE daily email newsletter.
